BioVie Announces Efficacy Data from Phase 3 Trial of
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker...
Source: globenewswire.com
Stay updated with breaking news from Biologically Active. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker...
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker…
Over the past few years – during which a once-in-a-century pandemic made a clutch of megacap biotech companies a lot of money – the health care industry has...
Market Highlights: Aussie becomes first to sue ChatGPT for defamation, and 5 ASX small caps to watch today